Intended for healthcare professionals


In brief

BMJ 2005; 330 doi: (Published 10 February 2005) Cite this as: BMJ 2005;330:324

Warning issued on rare side effect of ADHD drug: The Medicines and Healthcare Products Regulatory Agency has warned doctors and patients that atomoxetine (Strattera)—used to treat attention-deficit/hyperactivity disorder (ADHD) in children—may be associated with liver problems in 1 in 50 000 cases.

India launches first HIV vaccine trial: The Indian Council of Medical Research last week began human trials of a …

View Full Text

Log in

Log in through your institution


* For online subscription